Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
더 보기
CEO
Dr. Sammy J. Farah M.B.A., Ph.D.
직원
14
국가
미국
ISIN
US90042W1009
상장
댓글 0개
생각을 공유하기
자주 묻는 질문
오늘 Turnstone Biologics 주가는 얼마인가요?▼
TSBX의 현재 가격은 $0.36 USD이며, 지난 24시간 동안 +1.43% 상승했습니다. 차트에서 Turnstone Biologics 주가 흐름을 더 자세히 살펴보세요.
Turnstone Biologics의 주식 심볼은 무엇인가요?▼
거래소에 따라 주식 심볼이 다를 수 있습니다. 예를 들어, XNAS 거래소에서는 Turnstone Biologics 주식이 TSBX 심볼로 거래됩니다.